Skip to Main Content

Clinical Studies and Protocols

Site Map Investigators Log-in
(JKR-0397) Collection of blood specimens for research purposes


 Return to List of Clinical Studies
 Return to List of Protocols for Psoriasis and Skin Diseases
Collection of blood specimens for research purposes (JKR-0397

Principal Investigator:
James G. Krueger M.D., Ph.D.

Investigators:

Contact Information:
Patricia Gilleaudeau
Rockefeller University
1230 York Avenue
New York, NY 10065
Telephone: 212-327-8333
FAX: 212-327-8232
Email: gilleap@rockefeller.edu
Contact Information:
Mary Sullivan-Whalen
Telephone: 212-327-7212
Alt. Telephone:
E-Mail: whalems@rockfeller.edu


Enrollment Status:
Closed to Enrollment

Brief Summary of Protocol:
The investigators at The Rockefeller University are currently conducting research studies on the following:
- Biology of Addictive Diseases
- Clinical Studies of Obesity
- Dentritic Cell Mediated Immunization
- Diabetes Type 2
- Evaluating New Treatments of HIV/AIDS
- Fanconi Anemia
- Genetic Basis for Premature Coronary Heart Disease
- Genetic Studies of Obesity
- Paraneoplastic Neurologic Disorders
- Psoriasis studies
- Vitiligo studies
- Hepatitis C studies
- others
Investigators need to study patients with defined diseases as well as normal healthy controls. We are trying to gain a better understanding of the above mentioned diseases.




Detailed Description of Protocol:
Blood will be taken sterilely from a vein in your arm. No more than 550 ml (18 ounces) of blood will be drawn in any 8 week period.

If you are under 18 years the amount of blood will be no more than 50 ml (slightly less than 2 ounces) or 3 ml (slightly less than 1 teaspoon) per kg of body weight in an 8 week period and not more than 2 times per week. Profile:
If you join the research study, you will take part for less than 15 minutes per visit.

The research study as a whole will last up to one year.

More than 100 people will take part in the research study.



What specifically makes a person eligible for the study?
You may be eligible to enter this study:

Patient or Healthy Volunteer

Gender:
Both

Age(s):
12 years and older

Children permitted to participate:
Yes

Potential Benefits.....
There will be no direct benefit to you. Instead, others may benefit in the future from what we learn from this study.



Compensation:
There is no compensation for participation in this research study.